ICD-10-GM

ICD-10-GM-Code D69.1

You are here: Startseite > ICD-10-GM > D50-D89 > D65-D69 > D69

- ICD-10-GM
Internationale statistische Klassifikation der Krankheiten und verwandter Gesundheitsprobleme (ICD-10)
- D50-D89
Krankheiten des Blutes und der blutbildenden Organe sowie bestimmte Störungen mit Beteiligung des Immunsystems
- D65-D69
Koagulopathien, Purpura und sonstige hämorrhagische Diathesen
- D69
Purpura und sonstige hämorrhagische Diathesen

D69.1

Qualitative Thrombozytendefekte

ICD-10-GM Code D69.1 für Qualitative Thrombozytendefekte

Bernard-Soulier-Syndrom [Riesenthrombozyten-Syndrom]

Glanzmann- (Naegeli-) Syndrom

Grey-platelet-Syndrom [Syndrom der grauen Thrombozyten]

Thrombasthenie (hämorrhagisch) (hereditär)

Thrombozytopathie

Exkl.: Willebrand-Jürgens-Syndrom (D68.0)

ICD-10
ATC
ICD-10 International Statistical Classification of Diseases and Related Health Problems 10th Revision
ICD-10

ICD-10 is the 10th revision of the International Statistical Classification of Diseases and Related Health Problems (ICD), a medical classification list by the World Health Organization (WHO).

It contains codes for diseases, signs and symptoms, abnormal findings, complaints, social circumstances, and external causes of injury or diseases.

ATC

The Anatomical Therapeutic Chemical (ATC) Classification System is used for the classification of active ingredients of drugs according to the organ or system on which they act and their therapeutic, pharmacological and chemical properties.

It is controlled by the World Health Organization Collaborating Centre for Drug Statistics Methodology (WHOCC).

DDD

The defined daily dose (DDD) is a statistical measure of drug consumption, defined by the World Health Organization (WHO).

It is used to standardize the comparison of drug usage between different drugs or between different health care environments.

Home Contact Us